Retour
Fourchette du Jour
16,33 €
16,91 €
Fourchette 52 Semaines
16,08 €
34,52 €
Volume
9 254 318
Moyenne 50J / 200J
19,69 €
/
22,59 €
Clôture Précédente
16,15 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -8,9 | 0,4 |
| P/B | 1,4 | 2,9 |
| ROE % | -14,6 | 3,8 |
| Net Margin % | -8,5 | 3,9 |
| Rev Growth 5Y % | -1,9 | 10,0 |
| D/E | 1,6 | 0,2 |
Points Clés
Revenue declined -1,91% annually over 5 years
Generating 323,00M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7,63%
Capital efficient — spends only 4,64% of revenue on capex
Croissance
Revenue Growth (5Y)
-1,91%
Revenue (1Y)5,72%
Earnings (1Y)N/A
FCF Growth (3Y)-49,96%
Qualité
Return on Equity
-14,62%
ROIC-1,43%
Net Margin-8,51%
Op. Margin-2,74%
Sécurité
Debt / Equity
1,63
Current Ratio2,31
Interest Coverage-1,06
Valorisation
P/E Ratio
-8,93
P/B Ratio1,39
EV/EBITDAN/A
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,72% | Revenue Growth (3Y) | 4,18% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -1,91% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 11,24B | Net Income (TTM) | -957,00M |
| ROE | -14,62% | ROA | -4,77% |
| Gross Margin | 30,05% | Operating Margin | -2,74% |
| Net Margin | -8,51% | Free Cash Flow (TTM) | 323,00M |
| ROIC | -1,43% | FCF Growth (3Y) | -49,96% |
| Safety | |||
| Debt / Equity | 1,63 | Current Ratio | 2,31 |
| Interest Coverage | -1,06 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | -8,93 | P/B Ratio | 1,39 |
| P/S Ratio | 0,76 | PEG Ratio | -0,27 |
| EV/EBITDA | N/A | Dividend Yield | 0,04% |
| Market Cap | 8,55B | Enterprise Value | 16,58B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11,24B | 10,64B | 10,36B | 10,06B | 12,15B |
| Net Income | -957,00M | -649,00M | 2,66B | -2,43B | 1,28B |
| EPS (Diluted) | -1,75 | -1,27 | 5,23 | -4,83 | 2,53 |
| Gross Profit | 3,38B | 3,98B | 4,15B | 3,55B | 4,72B |
| Operating Income | -308,00M | 14,00M | 707,00M | -2,85B | 1,35B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 20,06B | 25,78B | 28,28B | 28,29B | 33,52B |
| Total Liabilities | 13,95B | 18,76B | 19,81B | 22,39B | 24,40B |
| Shareholders' Equity | 6,13B | 6,96B | 8,40B | 5,83B | 9,08B |
| Total Debt | 10,00B | 13,45B | 14,11B | 17,20B | 18,31B |
| Cash & Equivalents | 1,97B | 1,76B | 3,08B | 1,72B | 2,95B |
| Current Assets | 6,87B | 8,85B | 9,60B | 8,01B | 8,87B |
| Current Liabilities | 2,97B | 6,51B | 6,50B | 4,75B | 4,24B |